- European Court bans stem cell patents
- Behind the Bench: A series about researchers and their rituals
- Clinical trials news and information
- Stem cells and disease research: challenges for iPS cells
- Workshop on stem cell therapy for neurological diseases, on Twitter
- Stem cell fact sheets: Regeneration: what does it mean and how does it work?
- Research updates from EU projects: Pioneering stem cell science using biological and computational expertise
- Stem cell toolkit: Ready or not? A role play on taking stem cells into the clinic
- Stem cell resources: recent additions to our directory
Welcome to our second newsletter
Hi! The year is flying by and here we are with our second quarterly newsletter already. We've got lots of news to share - from stem cell patents to clinical trials updates, a new guest blogger, factsheets, educational tools and more. For more regular updates, you can also follow us on Twitter, check out our Facebook page or subscribe to our RSS feeds. And if you haven't visited the site for a while, do take a look and get in touch with your feedback and ideas.
You have received this newsletter because you have signed up to the EuroStemCell site, or have been involved in a related project. If you do not wish to receive subsequent editions, please use the unsubscribe link at the bottom of this message.
European Court bans stem cell patents
The European Court of Justice has today announced a landmark decision banning patenting of inventions based on embryonic stem cells. Scientists are concerned that the verdict, which is legally binding for all EU states, will drive development of stem cell therapies outside Europe.
Behind the Bench: A series about researchers and their rituals
A new series of blogs providing an insider’s perspective on stem cell research and the people involved in it. Written by Anestis Tsakiridis, a researcher at the University of Edinburgh. In this first blog: meet Anestis and find out what he'll be writing about in the coming weeks.
Clinical trials news and information
We've launched a new clinical trials section on our site, designed to bring together news, frequently asked questions and valuable sources of further information on clinical research in stem cells and regenerative medicine.
Before new treatments can reach patients, they must be tested in clinical trials. The first in our series of clinical trials updates describes some stem-cell-related trials currently under way or recently approved.
What's covered in the September update?
We’ve focused on trials using embryonic stem cells or taking place in Europe, and cover spinal cord injury, Stargardt's macular dystrophy, age-related macular degeneration and stroke. We’ll post more updates on other themes in future, so tell us if there’s an area you really want to know about. Read more about clinical trials
Stem cells and disease research: challenges for iPS cells
The discovery that adult cells could be ‘reprogrammed’ and converted into stem cells caused a great deal of excitement among scientists. There are high hopes that this new technology will help us study, understand and eventually treat disease. But researchers still face a number of challenges, as shown by several recent studies and described by Edinburgh researcher Tilo Kunath in a commentary article for EuroStemCell.
Workshop on stem cell therapy for neurological diseases, on Twitter
Andrew Smith spent two days tweeting on our Twitter page @euro_dayinsci to share the discussions at a recent NeuroStemcell workshop on Stem cell therapy for neurological diseases: translation to the clinic. Even if you're not on Twitter it's worth checking out his updates for an overview of the interesting discussions between scientists, ethicists and others at the workshop - some fascinating topics!
Stem cell fact sheets
Regeneration: what does it mean and how does it work?Some parts of our bodies can repair themselves quite well after injury, but others don’t repair at all. We certainly can’t regrow a whole leg or arm, but some animals CAN regrow – or regenerate – whole body parts. So what can we learn from these regenerative animals?
Research updates from EU-funded stem cell projects
Our research updates keep you informed about progress in public-funded European stem cell research. Here's a recent example from our partner, EuroSyStem:
Pioneering stem cell science using biological and computational expertise
EuroSyStem began by bringing together leading stem cell scientists from eight European countries. Their aim was to further understand stem cell science by combining both biological and computational techniques. Understanding how stem cells work means that their potential for treating disease can be fully realized in the future. EuroSyStem has made significant progress in each of its scientific areas. It has also established a network of stem cell scientists, now spanning 17 countries and 61 research groups, and has provided quality training and collaborative research opportunities. Read more about EuroSyStem
Stem cell toolkit - new role play added to our kit
We're working hard on expanding the EuroStemCell toolkit - downloadable stem cell activities and resources for a variety of audiences and settings - and lots of tools are already available on our Toolkit page. Here's one of our latest additions...
Ready or not? A role play on taking stem cells into the clinic
A role play exploring the issues around taking stem cells to the clinic. The scenario is an open public hearing of a research ethics committee, to decide on granting a licence for a clinical trial using human embryonic stem cells to treat spinal cord injuries. Participants roleplay members of the committee and different stakeholders in the audience, and in doing so engage in debates on the scientific and social issues surrounding stem cell research.